PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsTvardi Therapeutics
Tvardi Therapeutics(TVRD)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Triapine
non-small-cell lung carcinoma
,
adenocarcinoma
,
adenocarcinoma of lung
Sominex
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
hemolytic-uremic syndrome
,
hemolysis
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
azotemia
,
multiple sclerosis
,
sclerosis
,
lupus nephritis
,
nephritis
,
chronic progressive multiple sclerosis
,
syndrome
,
kidney diseases
,
membranous glomerulonephritis
,
systemic lupus erythematosus
,
relapsing-remitting multiple sclerosis
,
nephrotic syndrome
,
nephrosis
,
lipoid nephrosis
,
rheumatoid arthritis
,
arthritis
,
renal insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use